About Us : Management | M’s Science Corporation

CEO and President Shiro Mita	Dr. Shiro Mita is the President and Chief Executive Officer of M’s Science Corporation since November 2000. Previously, Dr. Mita was the Executive Director of Drug Discovery at Santen Pharmaceuticals Co., Ltd from 1995 to 2000. Dr. Mita has a Ph.D. in Pharmaceutical Sciences from Tokyo University, after which he entered the School of Medicine of Keio University as a Research Associate. Dr. Mita obtained a Post-Doctoral Fellowship in cancer biology from the University of Washington in Seattle. Has been a member of the board of directors of Santen Pharmaceutical Co., Ltd from 1989 to 2000. Dr. Mita will bring to the board extensive experience in the biotechnology and pharmaceutical fields, both as a researcher and an executive officer.

CEO and President
Shiro Mita

Dr. Shiro Mita is the President and Chief Executive Officer of M’s Science Corporation since November 2000. Previously, Dr. Mita was the Executive Director of Drug Discovery at Santen Pharmaceuticals Co., Ltd from 1995 to 2000. Dr. Mita has a Ph.D. in Pharmaceutical Sciences from Tokyo University, after which he entered the School of Medicine of Keio University as a Research Associate. Dr. Mita obtained a Post-Doctoral Fellowship in cancer biology from the University of Washington in Seattle. Has been a member of the board of directors of Santen Pharmaceutical Co., Ltd from 1989 to 2000. Dr. Mita will bring to the board extensive experience in the biotechnology and pharmaceutical fields, both as a researcher and an executive officer.

Executive Managing Director of the Board, Executive Vice President of Research & Development Division Wakao Sato	Received his Master's degree of Pharmaceutical Science from Tokyo University. Joined Mitsui Pharmaceuticals Inc. (current Nihon Schering K.K.). Served as Head of the London office and as a Clinical Development Team Leader in the headquarters office of Schering AG in Berlin. Later became a Director of the Oncology Group in the Clinical Development Department in the headquarters office of Nihon Schering K.K. in Osaka. Joined M's Science as the Vice President of the Clinical Research Division II in January 2006, joined the Board of Directors in June 2006, and became the Chief Research & Development Officer in June 2007.

Executive Managing Director of the Board, Executive Vice President of Research & Development Division
Wakao Sato

Received his Master's degree of Pharmaceutical Science from Tokyo University. Joined Mitsui Pharmaceuticals Inc. (current Nihon Schering K.K.). Served as Head of the London office and as a Clinical Development Team Leader in the headquarters office of Schering AG in Berlin. Later became a Director of the Oncology Group in the Clinical Development Department in the headquarters office of Nihon Schering K.K. in Osaka. Joined M's Science as the Vice President of the Clinical Research Division II in January 2006, joined the Board of Directors in June 2006, and became the Chief Research & Development Officer in June 2007.